Del. Hemispherx Settlement Delayed By CEO's Fla. Case
A Delaware Chancery Court judge refused to rule Friday on the proposed settlement of a derivative suit brought by shareholders of Hemispherx Biopharma Inc. over executive and board bonuses, saying that...To view the full article, register now.
Already a subscriber? Click here to view full article